Top Logistics Companies To Invest In Right Now

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Universal Truckload Services (NASDAQ: UACL  ) , a North American provider of trucking and logistics solutions, jumped as much as 12% after receiving an upgrade from BB&T�Capital Markets.

So what: According to BB&T Capital Markets, Universal Truckload's product offerings should broaden and its gross margins should improve following its $335 million purchase of privately held LINC Logistics, announced last year. BB&T upgraded Universal Trucking to a buy from a hold and set its price target at $33, implying 32% upside based on Friday's closing price.

Now what: As usual, the first thing you need to do is not allow the extremely short-term movements of analysts to cloud your long-term investing thesis. In the case of Universal Truckload, it's going to be a bumpy ride but management seems to have the steering wheel pointed in the right direction. The purchase of LINC adversely affected the company's bottom line because of a change in tax code last quarter and Universal could suffer as it sheds lower margin and unprofitable operations. However, I do see value in the LINC purchase and feel, after a moderate pullback, that this could be a name worth keeping an eye on in the trucking sector.

Top Logistics Companies To Invest In Right Now: Skystar Bio-Pharmaceutical Company(SKBI)

Skystar Bio-Pharmaceutical Company engages in the research, development, production, marketing, and sale of veterinary healthcare and medical care products in the People?s Republic of China. Its products include veterinary medicine for poultry and livestock; micro-organism products; bio-pharmaceutical veterinary vaccines; and feed additives. The company offers its products through distributors and directly to customers. Skystar Bio-Pharmaceutical Company is headquartered in Xi?an, the People?s Republic of China.

Top Logistics Companies To Invest In Right Now: Smithfield Foods Inc.(SFD)

Smithfield Foods, Inc., together with its subsidiaries, engages in the production and marketing of fresh meat and packaged meats products in the United States and internationally. The company involves in the production of hog; and produces various fresh pork, beef, poultry, and packaged meats products. It sells fresh pork to retail customers as unprocessed and trimmed cuts, such as butts, loins, picnics, and ribs; packaged meats products, including smoked and boiled hams, bacon, sausage, hot dogs, and deli and luncheon meats; specialty products, such as pepperoni and dry meat products; and ready-to-eat prepared foods comprising pre-cooked entrees, and pre-cooked bacon and sausages. The company offers its products to supermarket chains; wholesale distributors; the foodservice industry, including fast food, restaurant and hotel chains, hospitals, and other institutional customers; export markets; and other further processors. It sells its products through its salespersons an d independent commission brokers. Smithfield Foods, Inc. was founded in 1961 and is headquartered in Smithfield, Virginia.

Top Canadian Stocks For 2014: Pacgen Biopharmaceuticals Corpo (PGA.V)

Pacgen Life Science Corporation, a life science technology company, focuses on the commercialization of biomedical products and services. It offers lab equipment, such as Fit X1 401, an automated, high-precision pipetting system designed to replace the manual process of PCR/qPCR sample preparation; electronic pipettes; and A + Pipette Controller, an electronic pipette controller designed for use with graduated and volumetric glass and plastic pipets. The company also provides reagent kits. In addition, it develops novel therapeutic drug candidates. Its product candidates include PAC-113, an anti-fungal drug, which has completed a Phase IIb clinical trial for the treatment of oral Candidiasis; and PAC-G31P, a novel peptide therapeutic, which is in preclinical studies for the treatment of inflammatory diseases characterized by non-beneficial neutrophil. The company has license agreement with Demegen, Inc. to expand its exclusive worldwide rights and license to PAC-113 for ad ditional indications, including vaginal, dermatological, and ophthalmic applications. It was formerly known as Pacgen Biopharmaceuticals Corporation and changed its name to Pacgen Life Science Corporation in April 2012. The company was founded in 2004 and is headquartered in Vancouver, Canada.